Humanized monoclonal antibody MEDI-522
| Humanized monoclonal antibody MEDI-522 | |
|---|---|
| Term | Humanized monoclonal antibody MEDI-522 |
| Short definition | humanized monoclonal antibody MEDI-522 (HYOO-muh-nized MAH-noh-KLOH-nul AN-tee-BAH-dee…) A substance being studied to treat some cancers and other diseases will. The humanized monoclonal antibody MEDI-522 binds to a protein on the surface of blood vessels and can prevent the growth of new blood vessels that tumors need to grow. It can also prevent the spread of cancer. It's a type of anti-angiogenesis drug, a type of anti-metastatic drug, and a type of monoclonal antibody. Also called Abegrin, etaracizumab and MEDI-522 |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
humanized monoclonal antibody MEDI-522 - (pronounced) (HYOO-muh-nized MAH-noh-KLOH-nul AN-tee-BAH-dee…) A substance being studied to treat some cancers and other diseases will. The humanized monoclonal antibody MEDI-522 binds to a protein on the surface of blood vessels and can prevent the growth of new blood vessels that tumors need to grow. It can also prevent the spread of cancer. It's a type of anti-angiogenesis drug, a type of anti-metastatic drug, and a type of monoclonal antibody. Also called Abegrin, etaracizumab and MEDI-522
External links
- Medical encyclopedia article on Humanized monoclonal antibody MEDI-522
- Wikipedia's article - Humanized monoclonal antibody MEDI-522
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski